RTA Laboratuvarlari Biyolojik Cash Flow Conversion Efficiency

Latest as of June 2025: 0.010x

RTA Laboratuvarlari Biyolojik cash flow conversion efficiency. Based on the latest financial reports, RTA Laboratuvarlari Biyolojik (RTALB) has a cash flow conversion efficiency ratio of 0.010x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (TL20.98 Million ≈ $469.96K USD) by net assets (TL2.12 Billion ≈ $47.58 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of RTA Laboratuvarlari Biyolojik (2010–2024)

Cash flow conversion efficiency of RTA Laboratuvarlari Biyolojik from 2010 to 2024. This chart illustrates how RTA Laboratuvarlari Biyolojik's cash flow conversion efficiency has evolved over time, based on yearly financial data. View RTALB share price today for real-time trading data and today's change.

RTA Laboratuvarlari Biyolojik Cash Flow Conversion Ratio Explained

RTA Laboratuvarlari Biyolojik cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

RTA Laboratuvarlari Biyolojik Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of RTA Laboratuvarlari Biyolojik ranked by their cash flow conversion efficiency. Also see market value of RTA Laboratuvarlari Biyolojik for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Kadimastem Ltd TA:KDST	0.072x
Assems Inc. KQ:136410	0.026x
Asiaplast Industries Tbk JK:APLI	-0.005x
Gillanders Arbuthnot & Company Limited NSE:GILLANDERS	0.008x
Pelayaran Nelly Dwi Putri Tbk JK:NELY	-0.002x
Acarix A/S ST:ACARIX	-0.270x
EMB Mission Bound AB (publ) ST:NAVIGO-STAM	0.033x
Finebesteel KO:133820	0.013x

Annual Cash Flow Conversion Efficiency for RTA Laboratuvarlari Biyolojik (2010–2024)

The table below shows the annual cash flow conversion efficiency of RTA Laboratuvarlari Biyolojik from 2010 to 2024. Review RTALB cash flow after capex ratio to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	TL1.67 Billion ≈ $37.38 Million	TL-84.45 Million ≈ $-1.89 Million	-0.051x	-212.98%
2023-12-31	TL1.62 Billion ≈ $36.21 Million	TL72.41 Million ≈ $1.62 Million	0.045x	+120.12%
2022-12-31	TL632.74 Million ≈ $14.17 Million	TL-140.82 Million ≈ $-3.15 Million	-0.223x	-211.06%
2021-12-31	TL343.23 Million ≈ $7.69 Million	TL68.78 Million ≈ $1.54 Million	0.200x	+258.87%
2020-12-31	TL167.81 Million ≈ $3.76 Million	TL9.37 Million ≈ $209.87K	0.056x	+35.39%
2019-12-31	TL86.69 Million ≈ $1.94 Million	TL3.58 Million ≈ $80.09K	0.041x	+140.54%
2018-12-31	TL57.06 Million ≈ $1.28 Million	TL-5.81 Million ≈ $-130.03K	-0.102x	-492.76%
2017-12-31	TL54.25 Million ≈ $1.22 Million	TL1.41 Million ≈ $31.47K	0.026x	-54.53%
2016-12-31	TL50.20 Million ≈ $1.12 Million	TL2.86 Million ≈ $64.05K	0.057x	-56.95%
2015-12-31	TL46.74 Million ≈ $1.05 Million	TL6.18 Million ≈ $138.52K	0.132x	+92.92%
2014-12-31	TL37.64 Million ≈ $843.11K	TL2.58 Million ≈ $57.83K	0.069x	-87.31%
2013-12-31	TL20.83 Million ≈ $466.61K	TL11.26 Million ≈ $252.28K	0.541x	+165.77%
2012-12-31	TL10.99 Million ≈ $246.17K	TL2.24 Million ≈ $50.08K	0.203x	+28.71%
2011-12-31	TL10.19 Million ≈ $228.27K	TL1.61 Million ≈ $36.08K	0.158x	-34.75%
2010-12-31	TL11.46 Million ≈ $256.76K	TL2.78 Million ≈ $62.20K	0.242x	--

About RTA Laboratuvarlari Biyolojik

IS:RTALB Turkey Biotechnology

Market Cap

$22.17 Million

TL990.00 Million TRY

Market Cap Rank

#24593 Global

#387 in Turkey

Share Price

TL1.98

Change (1 day)

+0.51%

52-Week Range

TL1.86 - TL4.71

All Time High

TL29.60